CWG
IBB icon

Cornerstone Wealth Group’s iShares Biotechnology ETF IBB Stock Holding History

Cornerstone Wealth Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Hold
1,213
– – 0.01% 440
2026
Q1 		$211K Hold
1,213
– – 0.01% 425
2025
Q4 		$205K Buy
+1,213
New +$197K 0.01% 376
2020
Q3 		– Sell
-31,977
Closed -$4.37M – 139
2020
Q2 		$4.37M Buy
+31,977
New +$4.08M 1.1% 21

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Cornerstone Wealth Group's IBB Position: Q2 2026 in Review

Cornerstone Wealth Group held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,213 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #440.

Cornerstone Wealth Group first reported a position in IBB in Q2 2020 and has held it in 4 quarters since. The position peaked at $4.37M in Q2 2020. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Cornerstone Wealth Group held 1,213 shares of iShares Biotechnology ETF worth $231K as of Q2 2026.
  • Cornerstone Wealth Group left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Cornerstone Wealth Group's portfolio in Q2 2026, its #440 holding.
  • Cornerstone Wealth Group first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 4 quarters since.
  • Cornerstone Wealth Group's iShares Biotechnology ETF position peaked at $4.37M in Q2 2020.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Cornerstone Wealth Group's 13F filing for Q2 2026, filed 27 Jul 2026.